• Explore /
  • Poster
  • / Baseline circulating myeloid-derived suppressor cells and response to PD-1 inhibitor in non-small cell lung cancer patients.

Baseline circulating myeloid-derived suppressor cells and response to PD-1 inhibitor in non-small cell lung cancer patients.

Abstract Poster

Authors

null

Myriam Delaunay

Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France

Myriam Delaunay, Nicolas Guibert, Amellie Lusque, Magali Farella, Nadia Boubekeur, Sandrine Gouin, Inge Dormoy, Pierre Fons, Michael Esquerre, Gilles Favre, Anne Pradines, Julien Mazieres

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies

Sub Track

Biomarkers and Inflammatory Signatures

Citation

J Clin Oncol 36, 2018 (suppl 5S; abstr 145)

DOI

10.1200/JCO.2018.36.5_suppl.145

Abstract #

145

Poster Bd #

H5

Abstract Disclosures

Similar Posters

First Author: Scott N. Gettinger

Poster

2023 ASCO Genitourinary Cancers Symposium

Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.

Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.

First Author: Nirmish Singla

First Author: Carlo Guerrero

First Author: Tony S. K. Mok